LAVA Therapeutics NV (LVTX)

NASDAQ
6.87
-0.26(-3.65%)
After Hours
6.82
-0.05(-0.73%)
- Real-time Data
  • Volume:
    39,436
  • Bid/Ask:
    6.60/6.90
  • Day's Range:
    6.61 - 7.03

LVTX Overview

Prev. Close
7.13
Day's Range
6.61-7.03
Revenue
5.1M
Open
7.03
52 wk Range
5.5-17.2
EPS
-1.32
Volume
39,436
Market Cap
177.08M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
153,175
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
25,775,538
Next Earnings Date
-
What is your sentiment on LAVA Therapeutics NV?
or
Market is currently closed. Voting is open during market hours.

LAVA Therapeutics NV News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuySellSellSellSell
Technical IndicatorsBuyBuyStrong SellNeutralNeutral
SummaryBuyNeutralStrong SellNeutralNeutral

LAVA Therapeutics NV Company Profile

LAVA Therapeutics NV Company Profile

Sector
Services
Employees
28

Lava Therapeutics B.V., a biotechnology company, engages in developing a portfolio of bispecific gamma-delta T cell engagers (gamma-delta bsTCEs) for the treatment of solid tumors and hematologic malignancies based on its platform. Its lead product candidate, LAVA-051, is advancing toward a Phase 1/2a clinical trial for the treatment of CD1d-expressing hematologic cancers, including chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia. The company also develops its gamma-delta bsTCEs in solid tumors, which targets prostate-specific membrane antigen for the treatment of prostate cancer. Lava Therapeutics B.V. has a research collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of potential product candidates. The company was incorporated in 2016 and is headquartered in Utrecht, the Netherlands.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.